![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Antiviral Efficacy of Entecavir in Black/African American and Hispanic Patients with Chronic Hepatitis B who are Nucleos(t)ide Naïve
|
|
|
Reported by Jules Levin
AASLD Nov 9-13 2012 Boston
Lennox Jeffers1, Christoffel J Van Rensburg2, Alpha Banks3, Mauro Schechter4, Stephen J Schmidt5, Wenhua Hu6, Raymundo Parana7, Cyril Llamoso6
1University of Miami, Center for Liver Diseases, Miami, FL, United States; 2Stellenbosch University and Louis Leipoldt Medical Centre, Bellville, Western Cape, South Africa; 3Banks Hepatology Institute Pc, College Park, MD, United States; 4Universidade Federal Do Rio De Janeiro, Rio De Janeiro, Brazil;
5Room 202 Medpark, Cor Syfred Douglas and Louwtjie Rothman Sts N1 City, Goodwood, Western Cape, South Africa; 6Research and Development, Bristol-Myers Squibb Company, Wallingford, CT, United States; 7Universidade Federal Da Bahia, Salvador, Brazil
![AASLD1.gif](../images/111912/111912-6/AASLD1.gif)
![AASLD2.gif](../images/111912/111912-6/AASLD2.gif)
![AASLD3.gif](../images/111912/111912-6/AASLD3.gif)
![AASLD4.gif](../images/111912/111912-6/AASLD4.gif)
![AASLD5.gif](../images/111912/111912-6/AASLD5.gif)
![AASLD6.gif](../images/111912/111912-6/AASLD6.gif)
![AASLD7.gif](../images/111912/111912-6/AASLD7.gif)
![AASLD8.gif](../images/111912/111912-6/AASLD8.gif)
![AASLD9.gif](../images/111912/111912-6/AASLD9.gif)
![AASLD10.gif](../images/111912/111912-6/AASLD10.gif)
![AASLD11.gif](../images/111912/111912-6/AASLD11.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|